Evidence map›Paper›PMID 30866532›Full record

ArticleMolecules (Basel, Switzerland)2019

Investigation on Spectrum-Effect Correlation between Constituents Absorbed into Blood and Bioactivities of Baizhu Shaoyao San before and after Processing on Ulcerative Colitis Rats by UHPLC/Q-TOF-MS/MS Coupled with Gray Correlation Analysis.

Hao Cai, Yangyang Xu, Li Xie, Yu Duan, Jia Zhou, Jing Liu, Minjie Niu, Yating Zhang, Lin Shen, Ke Pei and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Quality Markers ofFrontiers in nutrition · 2022
    Article
  4. Therapeutic mechanism ofFrontiers in pharmacology · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Processing and Polyherbal Formulation ofFrontiers in pharmacology · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hao CaiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. haocai_98@126.com.
Yangyang XuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. yangyangxu92@126.com.ORCID 0000-0003-4979-6727
Li XieSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. xl20160806@126.com.
Yu DuanSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. duanyu1681@sina.com.
Jia ZhouSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. zhoujia19931005@126.com.
Jing LiuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. 15951921665@163.com.
Minjie NiuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. someonearis@163.com.
Yating ZhangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. zhangyatingzyt@126.com.
Lin ShenSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. sonesunfany@sina.cn.
Ke PeiInstitute of Pharmaceutical and Food Engineering, Shanxi University of Traditional Chinese Medicine, Taiyuan 030024, China. peike_pk@126.com.
Gang CaoSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou 310053, China. caogang33@163.com.

Funding

National Natural Science Foundation of China 81503331National Natural Science Foundation of China 81573602National Natural Science Foundation of China 81673559National Natural Science Foundation of China 81673600Opening Project of Zhejiang Provincial First-rate Subject (Traditional Chinese Medicine), Zhejiang Chinese Medical University 2017005Opening Project of Zhejiang Provincial First-rate Subject (Traditional Chinese Medicine), Zhejiang Chinese Medical University Ya2017004Public Welfare Application Project of Zhejiang Province 2017C33174Traditional Chinese Medicine Key Scientific Research Fund Project of Zhejiang Province 2018ZY004
6 · The paper itself

Abstract

Baizhu Shaoyao San (BSS) is a crucial traditional Chinese medicinal formula widely applied for the treatment of painful diarrhea, diarrhea-predominant irritable bowel syndrome, ulcerative colitis, and some other gastrointestinal diseases. Corresponding to the clinical medication, the three medicinal herbs (Atractylodis Macrocephalae Rhizoma, Paeoniae Radix Alba, and Citri Reticulatae Pericarpium) included in BSS should be processed using some specific methods of stir-frying. To find the underlying correlations between serum chemical profiles and curative effects of crude and processed BSS on ulcerative colitis rats, and further explore for the effective material basis of processing, an UHPLC/Q-TOF-MS/MS technique coupled with gray correlation analysis (GCA) was developed. A total of 134 compounds were identified in rat sera after oral administration of BSS, among which 24 compounds were prototypes and 110 compounds were metabolites. Meanwhile, an ulcerative colitis model was established in rats by enema with 2,4,6-trinitrobenzene sulfonic acid, and the pharmacodynamic indicators for drug efficacies were evaluated as well. According to the results, processed BSS showed better efficacy than crude BSS. The top 10 potential effective components with high degree of correlation were identified based on GCA results, which were thought to be the crucial compounds that contributed to the enhancement of therapeutic effects in BSS after processing.

Indexed as

AnimalsBlood Chemical AnalysisChromatography, High Pressure LiquidColitis, UlcerativeCytokinesDisease Models, AnimalDrug CompoundingDrugs, Chinese HerbalMaleMolecular StructureRatsRats, Sprague-DawleyTandem Mass SpectrometryTrinitrobenzenesulfonic AcidCytokinesDrugs, Chinese HerbalTrinitrobenzenesulfonic AcidBaizhu Shaoyao Sangray correlation analysisspectrum-effect correlationUHPLC/Q-TOF-MS/MSulcerative colitis

Identifiers

PMID30866532
PMCPMC6429276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.